| 000 | 01616nam a2200265Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625124637.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-6161 | ||
| 245 | 1 | 0 | _aIdentifying essential genes in fungal pathogens of humans |
| 490 | 0 | _vTrends in MicroBiology, 10(10), p.456-462, 2002 | |
| 520 | 3 | _aOpportunistic fungal pathogens are an important cause of fatal invasive diseases and one of the many threats facing immunocompromised patients. Because of the limitations of the antifungal therapies currently available such as their toxicity, their narrow spectrum and the emergence of resistant pathogens, there is a significant demand for a broader antifungal arsenal. The characterization of genes essential for fungal growth will be an important step in the identification and development of novel antifungal drugs. Original strategies and new technologies including in vivo or in vitro transposon mutagenesis and post-transcriptional gene silencing are being developed for genome-scale identification of essential genes in fungal species that are pathogenic to humans. | |
| 650 | 1 | 4 | _aCANDIDA ALBICANS |
| 650 | 1 | 4 | _aASPERGILLUS FUMIGATUS |
| 650 | 1 | 4 | _aCRYPTOCOCCUS NEOFORMANS |
| 650 | 1 | 4 | _aANTIFUNGAL TARGET |
| 650 | 1 | 4 | _aRNAI |
| 650 | 1 | 4 | _aGENE SILENCING |
| 650 | 1 | 4 | _aTRANSPOSON MUTAGENESIS |
| 700 | 1 | 2 | _aFiron, A. |
| 700 | 1 | 2 | _ad'Enfert, C. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/1CfA8Gdfoc9vPIPisWVqGaZYkse-R7ADQ/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c40506 _d40506 |
||